NCT03309995View on ClinicalTrials.gov

The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

April 24, 2018

Study Completion Date

September 24, 2018

Conditions
Common ColdRespiratory Tract Infections
Interventions
DEVICE

Lozenges

The participants will be instructed to take 6 lozenges daily over the time awake, evenly distributed, allowing the lozenge to dissolve in the mouth as slowly as possible.

DEVICE

Placebo lozenges

Placebo lozenges

Trial Locations (1)

Unknown

City of Helsinki, Helsinki

All Listed Sponsors
collaborator

The University Pharmacy, Helsinki

UNKNOWN

lead

University of Helsinki

OTHER

NCT03309995 - The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold | Biotech Hunter | Biotech Hunter